Treatment of myoclonus-dystonia syndrome with tetrabenazine.

[1]  J. Rothwell,et al.  The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias. , 2014, JAMA neurology.

[2]  M. LeDoux,et al.  Incomplete nonsense‐mediated decay facilitates detection of a multi‐exonic deletion mutation in SGCE , 2013, Clinical genetics.

[3]  Nageswara Rao Pilli,et al.  Liquid chromatography-tandem mass spectrometric assay for the determination of tetrabenazine and its active metabolites in human plasma: a pharmacokinetic study. , 2013, Biomedical chromatography : BMC.

[4]  Andreea C. Bostan,et al.  Cerebellar networks with the cerebral cortex and basal ganglia , 2013, Trends in Cognitive Sciences.

[5]  Anand I. Rughani,et al.  Surgical treatment of myoclonus dystonia syndrome , 2013, Movement disorders : official journal of the Movement Disorder Society.

[6]  V. Dhawan,et al.  Metabolic changes in DYT11 myoclonus-dystonia , 2013, Neurology.

[7]  F. Baas,et al.  SGCE isoform characterization and expression in human brain: implications for myoclonus–dystonia pathogenesis? , 2011, European Journal of Human Genetics.

[8]  N. Nardocci,et al.  Myoclonus–dystonia syndrome: Clinical presentation, disease course, and genetic features in 11 families , 2008, Movement disorders : official journal of the Movement Disorder Society.

[9]  J. Jankovic,et al.  Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders , 2007, Movement disorders : official journal of the Movement Disorder Society.

[10]  Yuqing Li,et al.  Myoclonus, Motor Deficits, Alterations in Emotional Responses and Monoamine Metabolism in ε-Sarcoglycan Deficient Mice , 2006 .

[11]  J. Jankovic,et al.  Long-term effects of tetrabenazine in hyperkinetic movement disorders , 1997, Neurology.

[12]  P. Levitt,et al.  Central adrenergic receptor changes in the inherited noradrenergic hyperinnervated mutant mouse tottering , 1987, Brain Research.

[13]  J. Lorden,et al.  Alterations in the noradrenergic projection to the cerebellum of the dystonic (dt) rat , 1986, Brain Research.

[14]  G. Kirov,et al.  SGCE mutations cause psychiatric disorders: clinical and genetic characterization. , 2013, Brain : a journal of neurology.

[15]  Yuqing Li,et al.  Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. , 2006, Journal of biochemistry.

[16]  M. Hallett,et al.  The Unified Myoclonus Rating Scale. , 2002, Advances in neurology.